Dosage of recombinant Mycobacterium tuberculosis fusion protein for skin testing in the 18-65 year-old population and its safety in the 3-17 and 66-75 year-old populations: a randomized, blinded, positive-controlled phase Ⅱ clinical trial
Wang Jing, Wang Qingfeng, Jing Wei, Wang Yujin, Wang Xueyu, Huang Hairong, Chu Naihui, Nie Wenjuan
Chinese Journal of Antituberculosis
.
2025, (7): 840
-845
.
DOI: 10.19982/j.issn.1000-6621.20250067
|
|
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.